EXCLUSIVE AUDIO SERIES: Atopic Dermatitis Advisor
After reviewing notable safety considerations for systemic and topical Janus kinase inhibitors for patients with atopic dermatitis, Nicole Keeter, PA-C, describes steps she has taken to become more comfortable prescribing these agents to her patients with AD and discusses important tips for counseling these patients on adverse events and black box warnings.
Current issue
NP+PA Perspectives in Dermatology: December 2022
J Clin Aesthet Dermatol. 2022;15(12 Suppl 1) NP+PA Perspectives in Dermatology: December […]
Editorial Message: Matthew T. Reynolds, MS, MPAS, PA-C
J Clin Aesthetic Dermatol 2022;15(12 Suppl 1):S8 Dear Colleagues: This year, we […]
Spotlight Interview: Matthew T. Reynolds, MS, MPAS, PA-C
J Clin Aesthetic Dermatol 2022;15(12 Suppl 1):S13–S15 Matthew T. Reynolds, MS, MPAS, […]
An Updated Review of the Therapeutic Management of Keratoacanthomas
Reprinted with permission from J Clin Aesthet Dermatol. 2022;15(11):30–36 by Austin Ambur, […]
The Future of Contract Research Organizations in Dermatology and Aesthetic Research
Reprinted with permission from J Clin Aesthet Dermatol. 2022;15(9):16–19. by Mark Nestor, […]
NP+PA Perspectives in Dermatology: September 2022
J Clin Aesthet Dermatol. 2022;15(9 Suppl 1) NP+PA Perspectives in Dermatology: September […]
Dermatological Conditions in Skin of Color— Debunking Vitiligo Myths
J Clin Aesthet Dermatol. 2022;15(9 Suppl 1):S10–11 by Archana M. Sangha, MMS, […]